US equities
|
NVDA
$127.56
▼-12.62%
ANT
$87.04
▼-10.43%
MU
$591.28
▼-14.36%
AMD
$423.87
▼-13.35%
AAPL
$342.88
▼-1.81%
SPCX
$128.63
▼-7.08%
MSFT
$483.20
▼-3.03%
AMZN
$246.91
▼-4.07%
NVDA
$127.56
▼-12.62%
ANT
$87.04
▼-10.43%
MU
$591.28
▼-14.36%
AMD
$423.87
▼-13.35%
AAPL
$342.88
▼-1.81%
SPCX
$128.63
▼-7.08%
MSFT
$483.20
▼-3.03%
AMZN
$246.91
▼-4.07%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Latest News about e539ce9f/b59f/58d4/8994/72abaa5cf397
Recent news which mentions e539ce9f/b59f/58d4/8994/72abaa5cf397
Novavax tumbles 31% as waning COVID-19 vaccine demand hits revenue forecast
August 09, 2022
Tags
e539ce9f/b59f/58d4/8994/72abaa5cf397
fox/business/markets
article
From
FOX Business